Zitra Medicines
PrivateLast Round
Grant
Jul 1, 2025
Total Funding Raised
$320,000
Company Overview
Zitra Medicines operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Grant round in July 2025.
Zitra Medicines is a biotechnology company that develops mRNA-based therapeutics for severe brain diseases, including monogenic disorders, neurodegenerative conditions, and acute brain injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zitra Medicines Comparables
Compare Zitra Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ophidion Inc. | 81% | |
| Aerska | 80% | |
| Gate2Brain | 76% |
For institutional investors. Book with your work email.
Zitra Medicines Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Zitra Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| mRNA Victoria | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
$320K grant received from mRNA Victoria.
For institutional investors. Book with your work email.
Zitra Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zitra Medicines's valuation, stock price, and market status.
Is Zitra Medicines a public or private company?
Zitra Medicines is a private company.
What is the current stock price of Zitra Medicines?
Zitra Medicines is a private company, so its shares have no public market price. Caplight tracks Zitra Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zitra Medicines worth (valuation)?
Valuation information for Zitra Medicines is not publicly available.
Can I buy Zitra Medicines stock?
Zitra Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zitra Medicines's last funding round?
Zitra Medicines's most recent funding round was Grant on July 1, 2025.
Who are the main investors in Zitra Medicines?
Key investors in Zitra Medicines include mRNA Victoria.
Will Zitra Medicines IPO soon?
No public IPO plans have been announced for Zitra Medicines.
How can I track Zitra Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Zitra Medicines's shares on secondary markets.